Meena S. Moran, MD

• Henry S. Park
• Jun Deng
• Lynn D. Wilson
• Malini Harigopal
• Sanjay Aneja
• Suzanne B. Evans
• Veronika Shabanova
• Zhe Jay Chen

Complementary Therapies; Breast; Pelvis; Quality Assurance, Health Care; Quality of Health Care; Radiotherapy; Radiotherapy, Adjuvant

• Physician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United StatesPoli E, Chang C, Bleicher R, Moran M, Dietz J, Sarantou T, Kurtzman S, Yao K. Physician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United States. Annals Of Breast Surgery 2023, 0: 0-0. DOI: 10.21037/abs-22-1.
• Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None?Moran M, Ho A. Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None? Journal Of Clinical Oncology 2022, 40: 4166-4172. PMID: 36332170, DOI: 10.1200/jco.22.01751.
• 85: The Use of Bolus in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic ReviewDahn H, Boersma L, de Ruysscher D, Meattini I, Offersen B, Pignol J, Belkacemi Y, Benjamin D, Bese N, Coles C, Franco P, Ho A, Hol S, Jagsi R, Kirby A, Marrazzo L, Marta G, Moran M, Nichol A, Nissen H, Strnad V, Zissiadis Y, Aristei C, Poortman P, Kaidar-Person O. 85: The Use of Bolus in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic Review. Radiotherapy And Oncology 2021, 163: s38. DOI: 10.1016/s0167-8140(21)08963-5.
• 54: International Expert Delphi Consensus Guidelines for the Use of Bolus in Post Mastectomy Radiation TherapyDahn H, Boersma L, de Ruysscher D, Meattini I, Offersen B, Pignol J, Aristei C, Benjamin D, Bese N, Coles C, Franco P, Ho A, Hol S, Jagsi R, Kirby A, Marrazzo L, Marta G, Moran M, Nichol A, Nissen H, Strnad V, Zissiadis Y, Poortmans P, Kaidar-Person O. 54: International Expert Delphi Consensus Guidelines for the Use of Bolus in Post Mastectomy Radiation Therapy. Radiotherapy And Oncology 2021, 163: s26. DOI: 10.1016/s0167-8140(21)08932-5.
• ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality MeasuresBleicher R, Moran M, Ruth K, Edge S, Dietz J, Wilke L, Stearns V, Kurtzman S, Klein J, Yao K. ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Annals Of Surgical Oncology 2021, 28: 572-573. DOI: 10.1245/s10434-021-10535-8.
• CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are IrradiatedPeters G, Gao S, Knowlton C, Zhang A, Evans S, Higgins S, Wilson L, Saltmarsh N, Picone M, Moran M. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated. Journal Of The National Comprehensive Cancer Network 2021, 19: clo21-025. DOI: 10.6004/jnccn.2020.7707.
• Breast CancerKnowlton C, Moran M. Breast Cancer. 2020 DOI: 10.1891/9780826155146.0019.
• Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic FeaturesJagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Thomas T, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s7-s8. DOI: 10.1016/j.ijrobp.2019.06.392.
• PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDBChowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB. Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.
• EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast seriesLoganadane G, Kann B, Young M, Knowlton C, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast series. Radiotherapy And Oncology 2018, 127: s727-s728. DOI: 10.1016/s0167-8140(18)31638-4.
• EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast seriesLoganadane G, Kann B, Young M, Knowlton C, Evans S, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast series. Radiotherapy And Oncology 2018, 127: s724. DOI: 10.1016/s0167-8140(18)31631-1.
• Patterns of Care and Outcomes of Patients With Breast Cancer Who Refuse Recommended TherapyJohnson S, An Y, Kelly J, Aneja S, Mougalian S, Young M, Moran M, Evans S. Patterns of Care and Outcomes of Patients With Breast Cancer Who Refuse Recommended Therapy. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e20-e21. DOI: 10.1016/j.ijrobp.2017.06.639.
• The Impact of Standardized Treatment Planning Guidelines on Treatment Plan QualityKelly J, Park H, Carlson D, Moran M, Wilson L, Young M, Higgins S, Guay D, Arthur G, Simmons W, Winter S, Evans S. The Impact of Standardized Treatment Planning Guidelines on Treatment Plan Quality. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e556. DOI: 10.1016/j.ijrobp.2017.06.1936.
• Radiation Oncology Considerations in the Management of Mutation Carriers with Breast CancerMoran M. Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer. 2017, 151-170. DOI: 10.1007/978-3-319-59198-8_9.
• Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In SituMorrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Journal Of Clinical Oncology 2016, 34: 4040-4046. PMID: 27528719, PMCID: PMC5477830, DOI: 10.1200/jco.2016.68.3573.
• Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic InstitutionsMoran M, Zhao Y, Ma S, Kirova Y, Fourquet A, Chen P, Hoffman K, Hunt K, Wong J, Halasz L, Freedman G, Prosnitz R, Yassa M, Nguyen D, Hijal T, Haffty B, Wai E, Truong P. Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s144. DOI: 10.1016/j.ijrobp.2016.06.349.
• La Danse d'un Cygne (The Dance of a Swan)Moran M. La Danse d'un Cygne (The Dance of a Swan). International Journal Of Radiation Oncology • Biology • Physics 2016 DOI: 10.1016/j.ijrobp.2016.06.2451.
• Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network : JNCCN 2016, 14: 324-54. PMID: 26957618, DOI: 10.6004/jnccn.2016.0037.
• Radiosensitization effect of Huaier on breast cancer cellsDING X, YANG Q, KONG X, HAFFTY BG, GAO S, MORAN MS. Radiosensitization effect of Huaier on breast cancer cells. Oncology Reports 2016, 35: 2843-2850. PMID: 26935024, DOI: 10.3892/or.2016.4630.
• Recent Updates in the Management of Triple Negative Breast CancerSanft T, Moran M. Recent Updates in the Management of Triple Negative Breast Cancer. TouchREVIEWS In Oncology & Haematology 2016, 12: 36. DOI: 10.17925/ohr.2016.12.01.36.
• Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast CancerDeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci A. Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2015, 22: 3250-3256. PMID: 26202554, PMCID: PMC4696114, DOI: 10.1245/s10434-015-4666-1.
• Radiation therapy in the locoregional treatment of triple-negative breast cancerMoran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet Oncology 2015, 16: e113-e122. PMID: 25752562, DOI: 10.1016/s1470-2045(14)71104-0.
• Nomogram for Predicting the Risk of Locoregional Recurrence in Patients Treated With Accelerated Partial-Breast IrradiationWobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for Predicting the Risk of Locoregional Recurrence in Patients Treated With Accelerated Partial-Breast Irradiation. International Journal Of Radiation Oncology • Biology • Physics 2014, 91: 312-318. PMID: 25446607, DOI: 10.1016/j.ijrobp.2014.09.029.
• In Reply to Morgan and VaidyaTruong PT, Smith SL, Moran MS. In Reply to Morgan and Vaidya. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: 967-968. PMID: 25585789, DOI: 10.1016/j.ijrobp.2014.07.047.
• Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.Wobb J, Chen P, Shah C, Moran M, Shaitelman S, Vicini F, Mbah A, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. Journal Of Clinical Oncology 2014, 32: 59-59. DOI: 10.1200/jco.2014.32.26_suppl.59.
• Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative PhenotypeGarg R, Housri N, Kongara S, Wu H, Schiff D, Moran M, Karantza V, Haffty B. Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s69-s70. DOI: 10.1016/j.ijrobp.2014.05.230.
• The Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for PathologistsSchnitt SJ, Moran MS, Houssami N, Morrow M. The Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Archives Of Pathology & Laboratory Medicine 2014, 139: 575-7. PMID: 25153620, DOI: 10.5858/arpa.2014-0384-ed.
• Intraoperative Accelerated Partial Breast Irradiation: Caution Still WarrantedMoran MS, Truong PT. Intraoperative Accelerated Partial Breast Irradiation: Caution Still Warranted. International Journal Of Radiation Oncology • Biology • Physics 2014, 89: 496-498. PMID: 24929161, DOI: 10.1016/j.ijrobp.2014.01.034.
• Should triple-negative breast cancer (TNBC) subtype affect local-regional therapy decision making?Moran MS. Should triple-negative breast cancer (TNBC) subtype affect local-regional therapy decision making? American Society Of Clinical Oncology Educational Book 2014, e32-6. PMID: 24857120, DOI: 10.14694/edbook_am.2014.34.e32.
• Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast CancerMoran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2014, 21: 704-716. PMID: 24515565, DOI: 10.1245/s10434-014-3481-4.
• ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.Halyard MY, Harris EE, Bailey L, Bellon JR, Freedman GM, Goyal S, Horst KC, Moran MS, Park CC, Suh WW, Toppmeyer D, Haffty BG. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology 2014, 28: 157-64, c3. PMID: 24701707.
• Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiationRutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation. Journal Of Radiation Oncology 2013, 3: 147-152. DOI: 10.1007/s13566-013-0129-0.
• Dosimetric and Clinical Predictors of the Development of Moist Desquamation in Breast Cancer IrradiationRutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and Clinical Predictors of the Development of Moist Desquamation in Breast Cancer Irradiation. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s210. DOI: 10.1016/j.ijrobp.2013.06.545.
• Should Low-Risk Patients Be Treated With Three-Dimensional Conformal Radiation Therapy–Accelerated Partial-Breast Irradiation in an Off-Protocol Setting?Moran MS. Should Low-Risk Patients Be Treated With Three-Dimensional Conformal Radiation Therapy–Accelerated Partial-Breast Irradiation in an Off-Protocol Setting? Journal Of Clinical Oncology 2013, 31: 4032-4037. PMID: 24081936, DOI: 10.1200/jco.2013.51.1642.
• Is Ki-67 Expression Prognostic for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast Conservation Therapy (BCT)?Hafeez F, Neboori HJ, Harigopal M, Wu H, Haffty BG, Yang Q, Schiff D, Moran MS. Is Ki-67 Expression Prognostic for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast Conservation Therapy (BCT)? International Journal Of Radiation Oncology • Biology • Physics 2013, 87: 344-348. PMID: 23910708, DOI: 10.1016/j.ijrobp.2013.05.052.
• The Relative Benefits of Tamoxifen in Older Women with T1 Early‐Stage Breast Cancer Treated with Breast‐Conserving Surgery and Radiation TherapyKhan AJ, Parikh RR, Neboori HJ, Goyal S, Haffty BG, Moran MS. The Relative Benefits of Tamoxifen in Older Women with T1 Early‐Stage Breast Cancer Treated with Breast‐Conserving Surgery and Radiation Therapy. The Breast Journal 2013, 19: 490-495. PMID: 23800027, DOI: 10.1111/tbj.12150.
• Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?Bai HX, Motwani SB, Higgins SA, Haffty BG, Wilson LD, Lannin DR, Evans SB, Moran MS. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? International Journal Of Clinical Oncology 2013, 19: 460-466. PMID: 23780727, DOI: 10.1007/s10147-013-0575-0.
• Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?Jones T, Neboori H, Wu H, Yang Q, Haffty BG, Evans S, Higgins S, Moran MS. Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer? Annals Of Surgical Oncology 2013, 20: 2866-2872. PMID: 23661183, PMCID: PMC5731457, DOI: 10.1245/s10434-013-2994-6.
• What Currently Defines a Breast Center? Initial Data From the National Accreditation Program for Breast CentersMoran MS, Kaufman C, Burgin C, Swain S, Granville T, Winchester DP. What Currently Defines a Breast Center? Initial Data From the National Accreditation Program for Breast Centers. JCO Oncology Practice 2013, 9: e62-e70. PMID: 23814526, PMCID: PMC3595452, DOI: 10.1200/jop.2012.000636.
• Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After MastectomyKhan A, Milgrom S, Barnard N, Higgins S, Moran M, Kim S, Goyal S, Alfaraj F, Haffty B. Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After Mastectomy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s141. DOI: 10.1016/j.ijrobp.2012.07.165.
• Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast CancerJones T, Neboori H, Haffty B, Wu H, Yang Q, Moran M. Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s141. DOI: 10.1016/j.ijrobp.2012.07.164.
• Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiationEvans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, Higgins SA, Moran MS. Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Practical Radiation Oncology 2012, 3: e55-e60. PMID: 24674321, DOI: 10.1016/j.prro.2012.06.007.
• SU‐E‐T‐289: On the Use of a Diode Array for the Commissioning of Dynamically‐Wedged Asymmetric Fields Generated by Varian EDW's in the Pinnacle Treatment Planning SystemAhmad M, Liu W, Deng J, Nguyen K, Wu D, Chen Z, Moran M, Nath R. SU‐E‐T‐289: On the Use of a Diode Array for the Commissioning of Dynamically‐Wedged Asymmetric Fields Generated by Varian EDW's in the Pinnacle Treatment Planning System. Medical Physics 2012, 39: 3770-3770. PMID: 28517261, DOI: 10.1118/1.4735357.
• Multi-Institutional Experience of Ductal Carcinoma In Situ in Black vs White Patients Treated With Breast-Conserving Surgery and Whole Breast Radiation TherapyNelson C, Bai H, Neboori H, Takita C, Motwani S, Wright JL, Hobeika G, Haffty BG, Jones T, Goyal S, Moran MS. Multi-Institutional Experience of Ductal Carcinoma In Situ in Black vs White Patients Treated With Breast-Conserving Surgery and Whole Breast Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: e279-e283. PMID: 22672752, DOI: 10.1016/j.ijrobp.2012.03.068.
• A Prospective, Multicenter Study of Complementary/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast CancerMoran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell S. A Prospective, Multicenter Study of Complementary/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 85: 40-46. PMID: 22658441, DOI: 10.1016/j.ijrobp.2012.03.025.
• ACR Appropriateness Criteria® Ductal Carcinoma in SituMoran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® Ductal Carcinoma in Situ. The Breast Journal 2011, 18: 8-15. PMID: 22107336, DOI: 10.1111/j.1524-4741.2011.01197.x.
• Raising the Bar for Breast Health Care in the United StatesMoran MS, Knobf MT. Raising the Bar for Breast Health Care in the United States. Women's Health Issues 2011, 22: e129-e133. PMID: 22037415, DOI: 10.1016/j.whi.2011.08.011.
• DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early-stage, Node-negative Breast Cancer Treated with Breast Conserving Surgery and Radiation TherapyTaunk N, Goyal S, Wu H, Moran M, Chen S, Haffty B. DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early-stage, Node-negative Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s63-s64. DOI: 10.1016/j.ijrobp.2011.06.128.
• The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and RadiotherapyNeboori H, Wu H, Schiff D, Goyal S, Moran M, Yang J, Hirshfield K, Haffty B. The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s62-s63. DOI: 10.1016/j.ijrobp.2011.06.126.
• Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT)Danish H, Goyal S, Taunk N, Wu H, Moran M, Haffty B. Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT). International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s214. DOI: 10.1016/j.ijrobp.2011.06.394.
• Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings?Bai H, Lannin D, Higgins S, Motwani S, Hafty B, Goyal S, Wilson L, Evans S, Moran M. Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s245. DOI: 10.1016/j.ijrobp.2011.06.1716.
• A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy.Moran M, Yang J, Ma S, Gaudreau B, Higgins S, Weidhaas J, Wilson L, Peschel R, Fass D, Rockwell S. A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy. Journal Of Clinical Oncology 2011, 29: 241-241. DOI: 10.1200/jco.2011.29.27_suppl.241.
• ACR Appropriateness Criteria® Locally Advanced Breast CancerMacDonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Moran M, Horst K, Haffty BG. ACR Appropriateness Criteria® Locally Advanced Breast Cancer. The Breast Journal 2011, 17: 579-585. PMID: 21906206, DOI: 10.1111/j.1524-4741.2011.01150.x.
• ACR Appropriateness Criteria® Conservative surgery and Radiation – Stage I and II Breast CarcinomaBellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® Conservative surgery and Radiation – Stage I and II Breast Carcinoma. The Breast Journal 2011, 17: 448-455. PMID: 21790842, DOI: 10.1111/j.1524-4741.2011.01132.x.
• Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial–mesenchymal transitionZhang X, Li X, Zhang N, Yang Q, Moran MS. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial–mesenchymal transition. Biochemical And Biophysical Research Communications 2011, 412: 188-192. PMID: 21810413, DOI: 10.1016/j.bbrc.2011.07.074.
• Using Nodal Ratios to Predict Risk of Regional Recurrences in Patients Treated with Breast Conservation Therapy with 4 or More Positive Lymph NodesCastrucci W, Lannin D, Haffty BG, Higgins SA, Moran MS. Using Nodal Ratios to Predict Risk of Regional Recurrences in Patients Treated with Breast Conservation Therapy with 4 or More Positive Lymph Nodes. International Scholarly Research Notices 2011, 2011: 874814. PMID: 22084784, PMCID: PMC3200302, DOI: 10.5402/2011/874814.
• SU‐E‐T‐485: Clinical Evaluation of Inverse Planning Models and IMRT Delivery Systems in the Framework of AAPM TG‐119 ProtocolAhmad M, Liu W, Lund M, Moran M, Richards P, Wu D, Chen Z, Deng J, Nath R. SU‐E‐T‐485: Clinical Evaluation of Inverse Planning Models and IMRT Delivery Systems in the Framework of AAPM TG‐119 Protocol. Medical Physics 2011, 38: 3600-3600. DOI: 10.1118/1.3612438.
• Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survivalMoran MS, Gonsalves L, Goss DM, Ma S. Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Breast Cancer Research And Treatment 2011, 128: 543-551. PMID: 21301957, PMCID: PMC3235412, DOI: 10.1007/s10549-011-1362-0.
• Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast-Conserving TherapyMoran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG. Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Therapy. International Journal Of Radiation Oncology • Biology • Physics 2010, 81: 1236-1243. PMID: 21093162, DOI: 10.1016/j.ijrobp.2010.07.031.
• Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast CancerPatel A, Goyal S, Moran M, Choi D, Haffty B. Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s213. DOI: 10.1016/j.ijrobp.2010.07.513.
• Racial Disparities in Treatment Outcomes for African American Women with Ductal Carcinoma In Situ Receiving Whole Breast Irradiation following Breast Conserving SurgeryNelson C, Goyal S, Moran M, Motwani S, Haffty B. Racial Disparities in Treatment Outcomes for African American Women with Ductal Carcinoma In Situ Receiving Whole Breast Irradiation following Breast Conserving Surgery. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s222. DOI: 10.1016/j.ijrobp.2010.07.533.
• Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast CancerParikh R, Khan A, Goyal S, Ahlawat S, Moran M, Haffty B. Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s228-s229. DOI: 10.1016/j.ijrobp.2010.07.548.
• Riluzole Increases Ionizing Radiation Related Cellular Toxicity in Metabotropic Glutamate Receptor 1 Positive Human Breast Cancer CellsAhlawat S, Khan A, Goyal S, Schiff D, Wu H, Moran M, Haffty B. Riluzole Increases Ionizing Radiation Related Cellular Toxicity in Metabotropic Glutamate Receptor 1 Positive Human Breast Cancer Cells. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s160. DOI: 10.1016/j.ijrobp.2010.07.394.
• Tamoxifen Confers a Limited Benefit in Older Women with Early Stage Breast CancerKhan A, Parikh R, Goyal S, Moran M, Haffty B. Tamoxifen Confers a Limited Benefit in Older Women with Early Stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s212-s213. DOI: 10.1016/j.ijrobp.2010.07.512.
• Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary EvaluationParikh RR, Haffty BG, Lannin D, Moran MS. Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation. International Journal Of Radiation Oncology • Biology • Physics 2010, 82: 7-13. PMID: 20950955, DOI: 10.1016/j.ijrobp.2010.08.027.
• 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapyPierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmaña J, Meirovitz A, Domchek S. 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy. European Journal Of Cancer Supplements 2010, 8: 55. DOI: 10.1016/s1359-6349(10)70034-3.
• Quality Measures, Standards, and Accreditation for Breast Centers in the United StatesMoran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality Measures, Standards, and Accreditation for Breast Centers in the United States. International Journal Of Radiation Oncology • Biology • Physics 2010, 76: 1-4. PMID: 20005450, DOI: 10.1016/j.ijrobp.2009.08.010.
• Does Compliance with Radiation Therapy Differ in African‐American Patients with Early‐Stage Breast Cancer?1Sharma C, Harris L, Haffty BG, Yang Q, Moran MS. Does Compliance with Radiation Therapy Differ in African‐American Patients with Early‐Stage Breast Cancer?1. The Breast Journal 2009, 16: 193-196. PMID: 20030649, DOI: 10.1111/j.1524-4741.2009.00874.x.
• Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy.Pierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmanya J, Meirovitz A, Domchek S. Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. Cancer Research 2009, 69: 959-959. DOI: 10.1158/0008-5472.sabcs-09-959.
• Identification of genes associated with multiple cancers via integrative analysisMa S, Huang J, Moran MS. Identification of genes associated with multiple cancers via integrative analysis. BMC Genomics 2009, 10: 535. PMID: 19919702, PMCID: PMC2785840, DOI: 10.1186/1471-2164-10-535.
• The Yale University Experience of Early‐Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical‐Pathologic Features, Long‐Term Outcomes, and Molecular Expression of COX‐2, Bcl‐2, and p53 as a Function of HistologyMoran MS, Yang Q, Haffty BG. The Yale University Experience of Early‐Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical‐Pathologic Features, Long‐Term Outcomes, and Molecular Expression of COX‐2, Bcl‐2, and p53 as a Function of Histology. The Breast Journal 2009, 15: 571-578. PMID: 19995377, DOI: 10.1111/j.1524-4741.2009.00833.x.
• Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-stage Breast Cancer Patients Treated with Breast Conservation TherapyMoran M, Yang Q, Goyal S, Haffty B. Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-stage Breast Cancer Patients Treated with Breast Conservation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s7-s8. DOI: 10.1016/j.ijrobp.2009.07.043.
• Mucinous (Colloid) Carcinoma of the Breast: Clinicopathologic Features & Long-term Outcomes of Women Treated with Breast-conserving TherapyParikh R, Taunk N, Moran M, Haffty B. Mucinous (Colloid) Carcinoma of the Breast: Clinicopathologic Features & Long-term Outcomes of Women Treated with Breast-conserving Therapy. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s200-s201. DOI: 10.1016/j.ijrobp.2009.07.464.
• Low-risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery and Radiotherapy: Comparison with Intergroup Study E5194Motwani S, Galper S, Goyal S, Moran M, Haffty B. Low-risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery and Radiotherapy: Comparison with Intergroup Study E5194. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s53-s54. DOI: 10.1016/j.ijrobp.2009.07.143.
• Prognostic Value of P53 Expression in Patients Treated with Breast Conserving TherapyRewari A, Goyal S, Taunk N, Wu H, Moran M, Haffty B. Prognostic Value of P53 Expression in Patients Treated with Breast Conserving Therapy. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s195. DOI: 10.1016/j.ijrobp.2009.07.452.
• Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT)Haffty B, Goyal S, Green C, Schiff D, Yang Q, Moran M, Kulkarni D, Ganesan S, Hirshfield K. Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT). International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s6. DOI: 10.1016/j.ijrobp.2009.07.040.
• Radiation Techniques and Toxicities for Locally Advanced Breast CancerMoran MS, Haffty BG. Radiation Techniques and Toxicities for Locally Advanced Breast Cancer. Seminars In Radiation Oncology 2009, 19: 244-255. PMID: 19732689, DOI: 10.1016/j.semradonc.2009.05.007.
• Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groupsHaffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals Of Oncology 2009, 20: 1653-1659. PMID: 19491284, DOI: 10.1093/annonc/mdp051.
• Clinicopathologic Significance of Excision Repair Cross-Complementation 1 Expression in Patients Treated With Breast-Conserving Surgery and Radiation TherapyGoyal S, Parikh RR, Green C, Schiff D, Moran MS, Yang Q, Haffty BG. Clinicopathologic Significance of Excision Repair Cross-Complementation 1 Expression in Patients Treated With Breast-Conserving Surgery and Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2009, 76: 679-684. PMID: 19464815, DOI: 10.1016/j.ijrobp.2009.02.050.
• Clinical-Pathologic Features and Long-Term Outcomes of Tubular Carcinoma of the Breast Compared With Invasive Ductal Carcinoma Treated With Breast Conservation TherapyLiu GF, Yang Q, Haffty BG, Moran MS. Clinical-Pathologic Features and Long-Term Outcomes of Tubular Carcinoma of the Breast Compared With Invasive Ductal Carcinoma Treated With Breast Conservation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: 1304-1308. PMID: 19386432, DOI: 10.1016/j.ijrobp.2008.12.070.
• Long‐term outcomes and clinicopathologic differences of African‐American versus white patients treated with breast conservation therapy for early‐stage breast cancerMoran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG. Long‐term outcomes and clinicopathologic differences of African‐American versus white patients treated with breast conservation therapy for early‐stage breast cancer. Cancer 2008, 113: 2565-2574. PMID: 18816610, DOI: 10.1002/cncr.23881.
• Ductal Carcinoma In Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary EvaluationParikh R, Haffty B, Moran M. Ductal Carcinoma In Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s150-s151. DOI: 10.1016/j.ijrobp.2008.06.481.
• Prognostic Implications of Mammographically Occult, Early Stage Breast Cancer Patients Treated with Breast Conservation TherapyYang T, Yang Q, Haffty B, Moran M. Prognostic Implications of Mammographically Occult, Early Stage Breast Cancer Patients Treated with Breast Conservation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s92. DOI: 10.1016/j.ijrobp.2008.06.976.
• Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapyYang Q, Moran MS, Haffty BG. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Research And Treatment 2008, 115: 343. PMID: 18516673, DOI: 10.1007/s10549-008-0068-4.
• Using Nodal Ratios to Predict the Risk of In-Field Regional Recurrences in Patients Treated With Breast Conservation Therapy in Patients With 4 or More Positive Lymph NodesCastrucci W, Haffty B, Moran M. Using Nodal Ratios to Predict the Risk of In-Field Regional Recurrences in Patients Treated With Breast Conservation Therapy in Patients With 4 or More Positive Lymph Nodes. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s212. DOI: 10.1016/j.ijrobp.2007.07.1179.
• Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast CancerMoran M, Harris L, Haffty B. Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s4-s5. DOI: 10.1016/j.ijrobp.2007.07.010.
• Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast CancerHaffty B, Moran M, Yang Q, Tan A, Reiss M. Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s27. DOI: 10.1016/j.ijrobp.2007.07.048.
• Clinical Utility of the Modified Segmental Boost Technique (MSBT)Higgins S, Castrucci W, Lund M, Ahmad M, Mason C, Roy P, Mickenzie A, Mani S, Moran M. Clinical Utility of the Modified Segmental Boost Technique (MSBT). International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s404-s405. DOI: 10.1016/j.ijrobp.2007.07.1535.
• SU‐FF‐T‐106: Clinical Implementation of Varian Enhanced Dynamic Wedges Into the Pinnacle Treatment Planning System: Monte Carlo Dosimetry and Patient‐Specific Quality Assurance TechniquesAhmad M, Deng J, Chen Z, Lund M, Kimmett J, Moran M, Nath R. SU‐FF‐T‐106: Clinical Implementation of Varian Enhanced Dynamic Wedges Into the Pinnacle Treatment Planning System: Monte Carlo Dosimetry and Patient‐Specific Quality Assurance Techniques. Medical Physics 2007, 34: 2425-2425. DOI: 10.1118/1.2760762.
• SU‐FF‐T‐361: Planning Study of Intensity‐Modulated and 3D Conformal Radiotherapy of Whole Pelvis Including Inguinal Lymphatics: Radiobiological Considerations for Designing New Fractionation SchemesAhmad M, Song H, Lund M, Niemierko A, Moran M, Weidhaas J, Higgins S, Chen Z, Deng J, Nath R. SU‐FF‐T‐361: Planning Study of Intensity‐Modulated and 3D Conformal Radiotherapy of Whole Pelvis Including Inguinal Lymphatics: Radiobiological Considerations for Designing New Fractionation Schemes. Medical Physics 2006, 33: 2129-2129. DOI: 10.1118/1.2241281.
• Imrt of whole pelvis and inguinal nodes: Evaluation of dose distributions produced by an inverse treatment planning systemAhmad M, Song H, Moran M, Lund M, Chen Z, Deng J, Haffty B, Nath R. Imrt of whole pelvis and inguinal nodes: Evaluation of dose distributions produced by an inverse treatment planning system. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s484-s485. DOI: 10.1016/j.ijrobp.2004.07.410.
• 1. Effects of Breast Conserving Therapy on Lactation after PregnancyMoran M. 1. Effects of Breast Conserving Therapy on Lactation after Pregnancy. The Cancer Journal 2003, 9: 485. DOI: 10.1097/00130404-200311000-00009.
• Improved treatment of the pelvis and inguinal nodes using the modified segmental boost technique: dosimetric evaluationMoran M, Lund M, Ahmad M, Gignac J, Breneman M, Dustin J, Trumpore S, Haffty B, Nath R. Improved treatment of the pelvis and inguinal nodes using the modified segmental boost technique: dosimetric evaluation. International Journal Of Radiation Oncology • Biology • Physics 2002, 54: 344-345. DOI: 10.1016/s0360-3016(02)03649-0.
• Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapyMoran M, Haffty B. Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapy. International Journal Of Radiation Oncology • Biology • Physics 1998, 40: 353-358. PMID: 9457821, DOI: 10.1016/s0360-3016(97)00573-7.
• Conservatively Treated Breast Cancer: Outcome by Histologic SubtypeHaffty B, Perrotta P, Ward B, Moran M, Beinfield M, McKhann C, Fischer D, Carter D. Conservatively Treated Breast Cancer: Outcome by Histologic Subtype. The Breast Journal 1997, 3: 7-14. DOI: 10.1111/j.1524-4741.1997.tb00134.x.